Citations

Institution: Mayo Clinic Clear

Showing 10 of 108162 citations.

The end of the Beginning: PD-1 Inhibition as the New Standard of Care First-Line Immunotherapy in Metastatic Melanoma
Cherington, Chad, Cherington, Chad C, Bryce, Alan H.

Melanoma Management | December 4, 2015 | Volume: 2 | Issue: 4 | Pages: 305-309

10.2217/mmt.15.32 | PMID 30190858 Get It

Do post-operative changes of neck–shaft angle and femoral component anteversion have an effect on clinical outcome following uncemented total hip arthroplasty?
Müller, Michael , Wassilew, Georgi I. , Duda, Georg N. , Perka, Carsten , Abdel, Matthew P.

The Bone & Joint Journal | December 4, 2015 | Volume: 97-B | Issue: 12 | Pages: 1615-1622

10.1302/0301-620x.97b12.34654 | PMID 26637674 Get It

The accurate reconstruction of hip anatomy and biomechanics is thought to be important in achieveing good clinical outcomes following total hip arthroplasty (THA). To this end some newer hip designs have introduced further modularity into the design of the femoral component such that neck­shaft angle and anteversion, which can be adjusted intra-operatively. The clinical effect of this increased modularity is unknown. We have investigated the changes in these anatomical parameters following conventional THA with a prosthesis of predetermined neck–shaft angle and assessed the effect of changes in the hip anatomy on clinical outcomes.In total, 44 patients (mean age 65.3 years (standard deviation (sd) 7); 17 male/27 female; mean body mass index 26.9 (kg/m²) (sd 3.1)) underwent a pre- and post-operative three-dimensional CT scanning of the hip. The pre- and post-operative neck–shaft angle, offset, hip centre of rotation, femoral anteversion, and stem alignment were measured. Additionally, a functional assessment and pain score were evaluated before surgery and at one year post-operatively and related to the post-operative anatomical changes.The mean pre-operative neck–shaft angle was significantly increased by 2.8° from 128° (sd 6.2; 119° to 147°) to 131° (sd 2.1; 127° to 136°) (p = 0.009). The mean pre-operative anteversion was 24.9° (sd 8; 7.9 to 39.1) and reduced to 7.4° (sd 7.3; -11.6° to 25.9°) post-operatively (p < 0.001). The post-operative changes had no influence on function and pain. Using a standard uncemented femoral component, high pre- and post-operative variability of femoral anteversion and neck–shaft angles was found with a significant decrease of the post-operative anteversion and slight increase of the neck–shaft angles, but without any impact on clinical outcome.Cite this article: Bone Joint J 2015;97-B:1615–22.
Quadricuspid Aortic Valve
Tsang, Michael, Abudiab, Muaz M. , Ammash, Naser M., Naqvi, Tasneem Z. , Edwards, William D. , Pellikka, Patricia A. , Tsang, Michael Y C, Nkomo, Vuyisile T. , Pellikka, Patricia A

Circulation | December 4, 2015 | Volume: 133 | Issue: 3 | Pages: 312-319

10.1161/circulationaha.115.017743 | PMID 26635401 Get It

Background— Quadricuspid aortic valve (QAV) is a rare congenital cardiac defect. This study sought to determine QAV frequency in a large echocardiography database, to characterize associated cardiovascular abnormalities, and to describe long-term outcomes. Methods and Results— Fifty patients (mean±SD age, 43.5±21.8 years at the time of the index diagnosis; female sex, 52%) received a diagnosis of QAV between January 1, 1975, and March 14, 2014 (frequency, 0.006%). The QAV was type A in 32% and type B in 32% (Hurwitz and Roberts classification). Aortic dilatation was present in 29% of the patients, and 26% had moderate or severe aortic valve regurgitation at the index diagnosis. Stenosis affected only 8% of the valves and was mild. Other findings, including abnormalities of other cardiac valves, septal defects, persistent left superior vena cava, and patent ductus arteriosus, were present in 32% of patients. During a mean±SD follow-up of 4.8±5.6 years, 8 patients underwent aortic valve surgery, with severe aortic valve regurgitation being the surgical indication in 7 patients. One patient with mild to moderate aortic valve regurgitation underwent aortic valve repair for obstruction of the left coronary ostium by the accessory cusp of QAV. No infective endocarditis or aortic dissection was found. Overall survival was 91.5% and 87.7% at 5 and 10 years. Conclusions— Aortic dilatation and other structural cardiac abnormalities were relatively common among patients with QAV. Aortic valve regurgitation was the predominant hemodynamic abnormality and the indication for aortic valve surgery in most patients who received surgery. Long-term survival was excellent.
Syntactic and semantic errors in radiology reports associated with speech recognition software
Ringler, Michael D. , Goss, Brian C., Bartholmai, Brian J. , Bartholmai, Brian J

Health Informatics Journal | December 3, 2015 | Volume: 23 | Issue: 1 | Pages: 3-13

10.1177/1460458215613614 | PMID 26635322 Get It

Speech recognition software can increase the frequency of errors in radiology reports, which may affect patient care. We retrieved 213,977 speech recognition software–generated reports from 147 different radiologists and proofread them for errors. Errors were classified as “material” if they were believed to alter interpretation of the report. “Immaterial” errors were subclassified as intrusion/omission or spelling errors. The proportion of errors and error type were compared among individual radiologists, imaging subspecialty, and time periods. In all, 20,759 reports (9.7%) contained errors, of which 3992 (1.9%) were material errors. Among immaterial errors, spelling errors were more common than intrusion/omission errors ( p < .001). Proportion of errors and fraction of material errors varied significantly among radiologists and between imaging subspecialties ( p < .001). Errors were more common in cross-sectional reports, reports reinterpreting results of outside examinations, and procedural studies (all p < .001). Error rate decreased over time ( p < .001), which suggests that a quality control program with regular feedback may reduce errors.
The Landscape of Prognostic Outlier Genes in High-Risk Prostate Cancer
Zhao, Shuang G. , Evans, Joseph R. , Kothari, Vishal , Sun, Grace Y. , Larm, Ashley, Mondine, Victor, Schaeffer, Edward M. , Ross, Ashley E. , Klein, Eric A. , Den, Robert B. , Dicker, Adam P. , Karnes, R. Jeffrey , Erho, Nicholas , Nguyen, Paul L. , Feng, Felix Y. , Zhao, Shuang G , Davicioni, Elai , Den, Robert B , Klein, Eric A , Dicker, Adam P

Clinical Cancer Research | December 2, 2015 | Volume: 22 | Issue: 7 | Pages: 1777-1786

10.1158/1078-0432.ccr-15-1250 | PMID 26631616 Get It

Abstract Purpose: There is a clear need to improve risk stratification and to identify novel therapeutic targets in aggressive prostate cancer. The goal of this study was to investigate genes with outlier expression with prognostic association in high-risk prostate cancer patients as potential biomarkers and drug targets. Experimental Design: We interrogated microarray gene expression data from prostatectomy samples from 545 high-risk prostate cancer patients with long-term follow-up (mean 13.4 years). Three independent clinical datasets totaling an additional 545 patients were used for validation. Novel prognostic outlier genes were interrogated for impact on oncogenic phenotypes in vitro using siRNA-based knockdown. Association with clinical outcomes and comparison with existing prognostic instruments was assessed with multivariable models using a prognostic outlier score. Results: Analysis of the discovery cohort identified 20 prognostic outlier genes. Three top prognostic outlier genes were novel prostate cancer genes; NVL, SMC4, or SQLE knockdown reduced migration and/or invasion and outlier expression was significantly associated with poor prognosis. Increased prognostic outlier score was significantly associated with poor prognosis independent of standard clinicopathologic variables. Finally, the prognostic outlier score prognostic association is independent of, and adds to existing genomic and clinical tools for prognostication in prostate cancer (Decipher, the cell-cycle progression signature, and CAPRA-S). Conclusions: To our knowledge, this study represents the first unbiased high-throughput investigation of prognostic outlier genes in prostate cancer and demonstrates the potential biomarker and therapeutic importance of this previously unstudied class of cancer genes. Clin Cancer Res; 22(7); 1777–86. ©2015 AACR.
25 GENOME EDITING OF SOMATIC CELL NUCLEAR TRANSFER DERIVED ZYGOTES BY CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS (CRISPR)/Cas9 GUIDE RNA INJECTION
Whitworth, Kristin M. , Murphy, Stephanie L. , Benne, Joshua A., Spate, Lee D., Hickey, Robert J. , Nyberg, Sandra, Wells, Kevin D. , Walters, Eric M. , Prather, Randall S.

Reproduction, Fertility and Development | December 2, 2015 | Volume: 28 | Issue: 2 | Pages: 142-143

10.1071/rdv28n2ab25 Get It

Recent applications of the clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 system have greatly improved the efficiency of genome editing in pigs. However, in some cases, genetically modified pig models need an additional modification to improve their application. The objective of this experiment was to determine whether a combination of somatic cell NT (SCNT) by using a previously modified donor cell line and subsequent zygote injection with CRISPR/Cas9 guide RNA to target a second gene would result in embryos and offspring successfully containing both modifications. Fibroblast cell lines were collected from fumarylacetoacetate hydrolase deficient (FAH–/–) fetuses and used as the donor cell line. Somatic cell NT was performed by standard technique. A CRISPR guide RNA specific for recombination activating gene 2 (RAG2) was designed and in vitro transcribed from a synthesised gBlock (IDT) containing a T7 promoter sequence, the CRISPR Guide RNA (20 bp), and 85 bp of tracer RNA. The gBlock was PCR amplified with Q5 polymerase (NEB, Ipswich, MA, USA) and in vitro transcribed with the MEGAshortscript™ T7 Transcription Kit (Life Technologies, Grand Island, NY, USA). Guide RNA (20 ng µL–1) and polyadenylated Cas9 (20 ng µL–1, Sigma, St. Louis, MO, USA) were co-injected into the cytoplasm of SCNT zygotes at 14 to 16 h after fusion and activation. Injected SCNT were then cultured in vitro in PZM3 + 1.69 mM arginine medium (MU1) to Day 5. Three embryo transfers were performed surgically into recipient gilts on Day 4 or 5 of oestrus (50, 62, or 70 embryos per pig) to evaluate in vivo development. The remaining embryos were cultured in MU1 to Day 7 and analysed for the presence of modifications to the RAG2 gene. Embryos were classified as modified if they contained an INDEL as measured by both gel electrophoresis and DNA sequencing of PCR amplicons spanning the targeted exon. The RAG2 modification rate was 83.3% (n = 6), of which 50% (n = 3) of the embryos contained biallelic modifications. All control embryos contained a wild-type RAG2 gene (n = 5). Embryo transfer resulted in a 33.3% pregnancy rate (1/3). The combination of SCNT and CRISPR/Cas9 zygote injection can be a highly efficient tool to successfully create pig embryos with an additional modification. This additional technique further improves the usefulness of already created genetically modified pig models. This study was funded by the National Institutes of Health via U42 OD011140.
Not just a fecal matter
Dronca, Roxana

Science Translational Medicine | December 2, 2015 | Volume: 7 | Issue: 316 | Pages: No page available

10.1126/scitranslmed.aad8023 Get It

Gut microbiota may modulate the efficacy and/or toxicity of immune checkpoint blockade therapy in cancer.
Impact of predictors upon the reduction of lipid parameters in family medicine practice
Doğaner, Yusuf Çetin , Angstman, Kurt B. , Rohrer, James E. , Merry, Stephen , Angstman, Kurt, Rohrer, James, Merry, Stephen P

Sao Paulo Medical Journal | December 2, 2015 | Volume: 133 | Issue: 5 | Pages: 428-434

10.1590/1516-3180.2014.00321501 | PMID 26648432 Get It

ABSTRACT CONTEXT AND OBJECTIVE: To evaluate predictors of changes in lipid parameters consisting of LDL-C (low-density lipoprotein cholesterol), TC (total cholesterol) and non-HDL-C (non-high density lipoprotein cholesterol) among primary care patients. DESIGN AND SETTING: Retrospective study conducted on family medicine patients. METHODS: Demographic features and other clinically relevant information were abstracted from medical records. The primary outcome was the difference in LDL-C level from initial testing to the index test. Secondary outcomes were the changes in TC and non-HDL-C levels between two measurements. RESULTS: Three hundred and eleven participants were included in the final secondary analysis. Multiple linear regression revealed that male patients (β = 4.97, P = 0.040), diabetes (β = 9.75, P = 0.003) and higher LDL-C levels at baseline (β = 0.35, P < 0.001) were positively associated with LDL variance, whereas longer time period (β = -0.15, P = 0.045) and familial hypercholesterolemia history (β = -7.56, P = 0.033) were negatively associated. Male patients (β = 8.45, P = 0.002), DM (β = 9.26, P = 0.011), higher TC levels at baseline (β = 0.35, P < 0.001) and taking statins (β = 7.31, P = 0.023) were positively associated with TC variance, whilst longer time period (β = -0.183, P = 0.031) and familial hypercholesterolemia (β = -10.70, P = 0.008) were negatively associated. CONCLUSION: In the present study, patients who were male, on statin treatment, diagnosed with diabetes and had higher baseline lipid values were more likely associated with better lipid outcomes at future testing.
Interindividual variability in the dose-specific effect of dopamine on carotid chemoreceptor sensitivity to hypoxia
Limberg, Jacqueline K. , Johnson, Blair D. , Holbein, Walter W., Ranadive, Sushant M. , Mozer, Michael T., Joyner, Michael J. , Ranadive, Sushant M. , Johnson, Blair D , Joyner, Michael J , Ranadive, Sushant

Journal of Applied Physiology | December 2, 2015 | Volume: 120 | Issue: 2 | Pages: 138-147

10.1152/japplphysiol.00723.2015 | PMID 26586909 Get It

Human studies use varying levels of low-dose (1-4 μg·kg −1 ·min −1 ) dopamine to examine peripheral chemosensitivity, based on its known ability to blunt carotid body responsiveness to hypoxia. However, the effect of dopamine on the ventilatory responses to hypoxia is highly variable between individuals. Thus we sought to determine 1) the dose response relationship between dopamine and peripheral chemosensitivity as assessed by the ventilatory response to hypoxia in a cohort of healthy adults, and 2) potential confounding cardiovascular responses at variable low doses of dopamine. Young, healthy adults ( n = 30, age = 32 ± 1, 24 male/6 female) were given intravenous (iv) saline and a range of iv dopamine doses (1–4 μg·kg −1 ·min −1 ) prior to and throughout five hypoxic ventilatory response (HVR) tests. Subjects initially received iv saline, and after each HVR the dopamine infusion rate was increased by 1 μg·kg −1 ·min −1 . Tidal volume, respiratory rate, heart rate, blood pressure, and oxygen saturation were continuously measured. Dopamine significantly reduced HVR at all doses ( P < 0.05). When subjects were divided into high ( n = 13) and low ( n = 17) baseline chemosensitivity, dopamine infusion (when assessed by dose) reduced HVR in the high group only ( P < 0.01), with no effect of dopamine on HVR in the low group ( P > 0.05). Dopamine infusion also resulted in a reduction in blood pressure (3 μg·kg −1 ·min −1 ) and total peripheral resistance (1–4 μg·kg −1 ·min −1 ), driven primarily by subjects with low baseline chemosensitivity. In conclusion, we did not find a single dose of dopamine that elicited a nadir HVR in all subjects. Additionally, potential confounding cardiovascular responses occur with dopamine infusion, which may limit its usage.
ASXL1 and CBL mutations are independently predictive of inferior survival in advanced systemic mastocytosis
Pardanani, Animesh , Finke, Christy M. , Zblewski, Darci, Abdelrahman, Ramy A., Wassie, Emnet A, Gangat, Naseema , Hanson, Curtis A. , Ketterling, Rhett P. , Tefferi, Ayalew , Pardanani, Animesh D, Lasho, Terra L. , Zblewski, Darci L, Ketterling, Rhett P

British Journal of Haematology | December 2, 2015 | Volume: 175 | Issue: 3 | Pages: 534-536

10.1111/bjh.13865 | PMID 26628266 Get It